Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents
CA 2095141 A1 · Owner: Hellstrom, Karl E. · Inventors: Hellstrom, Karl E.; Schreiber, George; Hellstrom, Ingegerd
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of inhibiting tumor growth and development are described in which a combination of anti-tumor antibodies and biologically active agents, such as chemotherapeutic drugs are utilized. The , combination of anti-tumor antibody such as the BR96 antibody, with a chemotherapeutic drug such as doxorubicin or mitomycin C, is shown to produce a synergistic effect to inhibit tumor development and tumor cell growth.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 18, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 18, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 18, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.